Newronika
Restores brain and body functions with neural devices based on biosignal decoding. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€34—50m (Dealroom.co estimates Sep 2019.)
Company register number MI1890329
Cologno Monzese Lombardy (HQ)
Financials
Estimates*
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | <1m | <1m | <1m |
| % growth | (18 %) | 26 % | (5 %) | (3 %) | (33 %) | 20 % | 11 % |
| EBITDA | (<1m) | <1m | (<1m) | (<1m) | (<1m) | - | - |
| % EBITDA margin | (40 %) | 6 % | (145 %) | (484 %) | (975 %) | - | - |
| Profit | <1m | <1m | (<1m) | (<1m) | (<1m) | - | - |
| % profit margin | 4 % | 67 % | (198 %) | (446 %) | (1036 %) | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Spinout | |
* | €1.7m | Seed | |
€350k | Seed | ||
€270k | Seed | ||
€650k | Seed | ||
* | €8.4m | Early VC | |
* | €2.5m | Grant | |
N/A | Early VC | ||
| Total Funding | €13.9m | ||
Related Content
Recent News about Newronika
EditMore about Newronika
EditDeveloper of a neuro-modulation device designed to restore brain and body functioning. The company's therapeutic device uses the retro-activity system to record brain activity and modulate neuro-stimulation to collect, analyze and interpret bio-signals, enabling patients to receive the right stimulation at the right moment to perform normal daily activities and improve their quality of life.
Keywords: Healthcare Devices, Services, Supplies, Brain Devices, Deep Brain Stimulation, Mental Fitness, Neuro Therapy, Neuromodulation Therapy, Therapeutic Instruments.
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.